Avapritinib
VOYAGER
Blueprint Medicines · Phase 3 · Completed · Enrollment 476
| Arm | Reported safety |
|---|---|
| Avapritinib 300 mg | n/r |
| Regorafenib 160 mg | n/r |
A count stays a count. This page does not turn a count into a percent.
GIST
Programs, trials, and reported response and survival for gastrointestinal stromal tumor.
Avapritinib
Blueprint Medicines · Phase 3 · Completed · Enrollment 476
| Arm | Reported safety |
|---|---|
| Avapritinib 300 mg | n/r |
| Regorafenib 160 mg | n/r |
A count stays a count. This page does not turn a count into a percent.